Literature DB >> 22935208

Effects of AFP gene silencing on apoptosis and proliferation of a hepatocellular carcinoma cell line.

Ling Zhang1, Tao He, Hong Cui, Yunjian Wang, Changshan Huang, Feng Han.   

Abstract

Alpha fetoprotein (AFP) is an oncoembryonal protein that is highly expressed in the majority of hepatocellular carcinomas. Previous studies have shown that AFP may be involved in multiple cell growth regulating, differentiating, and immunosuppressive activities. We investigated the effects of AFP gene silencing by siRNA on apoptosis and proliferation of hepatocellular carcinoma cell line EGHC-9901, which highly expresses AFP and may serve as an ideal model for investigation of AFP functions. siRNA expressing plasmid targeting the AFP gene was first established and subsequently transfected into hepatocellular carcinoma cell line EGHC-9901; cells were then divided into three groups: siRNA-afp, transfected with AFP-siRNA; siRNA-beta-actin, transfected with siRNA-beta-actin as the positive group; and vector control, transfected with empty vector as the blank control group. After G418 positive clone selection for a couple of weeks, Western blot and RT (reverse transcription)-PCR assay demonstrated that AFP expression was almost completely inhibited by siRNA-afp, which indicates that siRNA expressing plasmid targeting the AFP gene has been successfully established. Furthermore, MTT (methyl thiazolyl tetrazelium) assay showed that cells transfected with siRNA-afp proliferated at a significantly lower speed than the other two groups and flat plate clone formation assay also witnessed less clones with diameters of more than 75 μm in siRNA-afp immunofluorescence indicating that the apoptosis rate of cells transfected with siRNA-afp was significantly higher than the other two groups. Furthermore, flow cytometry manifested approximately 20% more cells of siRNA-afp within G1 phase than those of the negative group, indicating that inhibition of AFP expression may cause G1 phase arrest. Finally, Western blot and RT-PCR assay demonstrated that siRNA-afp induced a higher expression of caspase-3 than the other two groups whereas there was no difference in expression of caspase-8, caspase-9, and Bcl-2 between the three groups.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22935208

Source DB:  PubMed          Journal:  Discov Med        ISSN: 1539-6509            Impact factor:   2.970


  7 in total

Review 1.  Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.

Authors:  Jaleh Varshosaz; Maryam Farzan
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

Review 2.  How Dysregulated Ion Channels and Transporters Take a Hand in Esophageal, Liver, and Colorectal Cancer.

Authors:  Christian Stock
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

3.  MicroRNA-93 activates c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by directly inhibiting PTEN and CDKN1A.

Authors:  Katsuya Ohta; Hiromitsu Hoshino; Jinhua Wang; Shigeshi Ono; Yuuki Iida; Keisuke Hata; Sharon K Huang; Steven Colquhoun; Dave S B Hoon
Journal:  Oncotarget       Date:  2015-02-20

Review 4.  Alpha-Fetoprotein and Hepatocellular Carcinoma Immunity.

Authors:  Xiaoping Wang; Qiaoxia Wang
Journal:  Can J Gastroenterol Hepatol       Date:  2018-04-01

Review 5.  Novel Cellular Therapies for Hepatocellular Carcinoma.

Authors:  Harriet Roddy; Tim Meyer; Claire Roddie
Journal:  Cancers (Basel)       Date:  2022-01-20       Impact factor: 6.639

6.  Hepatitis B Virus X Protein Driven Alpha Fetoprotein Expression to Promote Malignant Behaviors of Normal Liver Cells and Hepatoma Cells.

Authors:  Mingyue Zhu; Yan Lu; Wei Li; Junli Guo; Xu Dong; Bo Lin; Yi Chen; Xieju Xie; Mengsen Li
Journal:  J Cancer       Date:  2016-05-12       Impact factor: 4.207

7.  Aberrant AFP expression characterizes a subset of hepatocellular carcinoma with distinct gene expression patterns and inferior prognosis.

Authors:  Wei Chen; Jianjun Peng; Jinning Ye; Weigang Dai; Guanghua Li; Yulong He
Journal:  J Cancer       Date:  2020-01-01       Impact factor: 4.207

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.